您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:Flora Growth Corp 2025年季度报告 - 发现报告

Flora Growth Corp 2025年季度报告

2025-05-13美股财报邵***
AI智能总结
查看更多
Flora Growth Corp 2025年季度报告

3230 W. Commercial Boulevard,Suite 180(Address of principal executive offices) Yes☒No☐ Non-accelerated filer☒Smaller reporting companyEmerging growth company As of May 9, 2025, the registrant had22,568,653shares of its common shares, no par value ("Common Shares") outstanding. Item 1. Financial StatementsItem 2. Management's Discussion and Analysis of Financial Condition and Results of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and Procedures Item 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits include projections and estimates concerning our possible or assumed future results of operations, financial condition, businessstrategies and plans, market opportunity, competitive position, industry environment, and potential growth opportunities.In some cases, you can identify forward-looking statements by terms such as "may", "will", "should", "believe", "expect", "could", "intend","plan", "anticipate", "estimate", "continue", "predict", "project", "potential", "target," "goal" or other words that convey the uncertainty Additionaothercomprehe #For the three months ended March 31,Balance, December 31, 202418,512$-$162,871$(221)$(158,140)$Equity issued for business combinations924-813--Restricted stock vested--8--SARs vested--163-- exchange differences (net of income taxes---620-----(758) For the three months ended March 31, Balance, December 31, 20238,935$-$149,093$(140)$(142,549)$ Options forfeited--(303)-303Restricted stock vested--14--Restricted stock cancelled(4)-(9)--Share issuance costs--16--Other comprehensive loss -exchange differences (net of income taxes---27-----(3,374)Balance, March 31, 20248,981$-$148,871$(113)$(145,620)$ Cash flows from operating activities: Adjustments to net loss: Depreciation and amortization182Share based compensation172 Asset impairments46Changes in financial instruments at fair value(305)Bad debt expense71Gain on disposal of insolvent subsidiaries(1,229)Interest expense51 Net change in non-cash working capital: Trade and other receivables(1,082)Inventory928Prepaid expenses and other assets(63)Trade payables and accrued liabilities(967)Net cash used in operating activities(2,728)Cash flows from financing activities:Loan borrowings1,083 Net cash used in investing activities Effect of exchange rate on changes on cash(50)Change in cash during the period(2,341)Cash and restricted cash at beginning of period6,052$3,711$ Common shares issued for business combinations$813$Debt issued for business combinations2,135Common shares issued for other agreements- The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.8 Flora Growth Corp. (the "Company" or "Flora") was incorporated under the laws of the Province of Ontario, Canada on March 13,2019. The Company is a manufacturer and distributor of global cannabis and pharmaceutical products and brands, building a Street, W Suite 5800, Toronto, Ontario, M5H 3S1, Canada and our principal place of business in the United States is located at 3230W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida 33309. The Company believes that its current level of cash is not sufficient to continue investing in growth, while at the same time meeting itsobligations as they become due. These conditions raise substantial doubt regarding the Company's ability to continue as a goingconcern for a period of at least one year from the date of issuance of these unaudited condensed interim consolidated financial obtaining credit from financial institutions or otherwise. The actual amount that the Company may be able to raise under thesealternatives will depend on market conditions and other factors. As it seeks additional sources of financing, there can be no assurance financing in the debt and equity capital markets is subject to several factors, including but not limited to market and economicconditions, the Company's performance and investor sentiment with respect to it and its industry. The unaudited condensed interim consolidated financial statements do not include any adjustments for the recovery and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Basis of consolidation These unaudited condensed interim consolidated financial statements include the accounts of the Company and its subsidiaries. Allintercompany balances and transactions were eliminated on consolidation. Subsidiaries are entities the Company controls when it isexposed, or has rights, to variable returns from its involvement in the entity and can affect those returns through its power to direct the Minimum bid price requirementOn February 25, 2025, the Company was notified by the Nasdaq Stock Market, LLC ("Nasdaq") that it